Mylan Says Teva's MS Drug IP Suit Doomed By Safe Harbor
Mylan Inc. on Friday asked a New York federal judge to toss a patent infringement suit over Teva Pharmaceutical Industries Ltd.'s Copaxone, saying it was permitted under a federal safe harbor...To view the full article, register now.
Already a subscriber? Click here to view full article